| Line item | 2026-01-31 FY | 2025-01-31 FY | 2024-01-31 FY | 2023-01-31 FY | 2021-01-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $52.73K |
| Cost of Revenue | – | $0.00 | $0.00 | $0.00 | $51.89K |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $958.35K | $1.03M | $1.17M | $1.73M | $1.22M |
| R&D | $307.87K | $331.58K | $404.87K | $781.78K | $153.28K |
| SG&A | – | – | – | – | – |
| Operating Income | -$958.35K | -$1.03M | -$1.17M | -$1.73M | – |
| Interest Expense | $83.84K | $39.02K | $38.91K | $38.91K | $244.27K |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | – |
| Net Income | $9.44M | -$1.10M | -$1.24M | -$1.80M | -$106.32K |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | 4.3700 | – | – | – | – |
| Shares (diluted) | $2.16M | – | – | – | – |